US FDA flags Cipla New York facility inspection with VAI
US FDA classifies Cipla subsidiary’s New York facility inspection as “Voluntary Action Indicated.”
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.